Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 2 | Breast Cancer Research

Fig. 2

From: Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26–30

Fig. 2

Breast cancer-specific and overall survival curves according to the 21-gene RS in sensitivity analyses that included breast cancer with HER2-positive, borderline, and unknown status in 2010–2015 (n = 20,943). a Breast cancer-specific survival and b overall survival according to RS groups. c Breast cancer-specific survival and d overall survival according to RS group by HER2 status

Back to article page